Results
1 -
10 of
17
(Click
here to explore results)
- Pharmacological and therapeutic properties of new derivatives of renin inhibitors and endothelin receptor antagonists, and the methods of their determination. Mariusz Stolarczyk, Anna Apola, Anna Maślanka, Jan Krzek
, Anal. Methods
, 2015
, 7
, 4419
- Combined computational/experimental investigation of new cocrystals of the drug bosentan. Rafael Barbas, Anna Portell, Christopher A. Hunter, Rafel Prohens, Antonio Frontera
, CrystEngComm
, 2022
, 24
, 5105
- Synthesis of novel 1,4-disubstituted 1,2,3-triazolo-bosentan derivatives – evaluation of antimicrobial and anticancer activities and molecular docking. K. Easwaramoorthi, A. Jeya Rajendran, K. Chennakesava Rao, Y. Arun, C. Balachandran, P. T. Perumal, Nobuhiko Emi, S. M. Mahalingam, V. Duraipandiyan, N. A. Al-Dhabi
, RSC Adv.
, 2015
, 5
, 105266
- Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach. Minyu Zhang, Hongwei Wu, Feifei Guo, Yangyang Yu, Junying Wei, Ya Geng, Shifeng Wang, Shiyou Li, Hongjun Yang
, Mol. BioSyst.
, 2017
, 13
, 1469
- A simple model to solve a complex drug toxicity problem. Vaibhav A. Dixit
, Toxicol. Res.
, 2019
, 8
, 157
- Design, synthesis and insecticidal activity of novel analogues of flubendiamide containing alkoxyhexafluoroisopropyl groups. Xianghu Zhao, Sixue Xu, Chuan Liu, Jingjing He, Chunmei Li, Yupian Deng, Song Cao
, RSC Adv.
, 2020
, 10
, 34486
- Liver organ-on-chip models for toxicity studies and risk assessment. Taha Messelmani, Lisa Morisseau, Yasuyuki Sakai, Cécile Legallais, Anne Le Goff, Eric Leclerc, Rachid Jellali
, Lab Chip
, 2022
, 22
, 2423
- Synthesis and biological evaluation of 4′-[(benzimidazol-1-yl) methyl]biphenyl-2-amides as dual angiotensin II and endothelin A receptor antagonists. Xiao-Feng Han, Wei-Zhe Xue, Li-Ping Hao, Zhi-Ming Zhou
, Med. Chem. Commun.
, 2015
, 6
, 1479
- Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar, Brijesh Rathi
, RSC Adv.
, 2021
, 11
, 36181
- Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations. Abd Al-Aziz A. Abu-Saleh, Ibrahim E. Awad, Arpita Yadav, Raymond A. Poirier
, Phys. Chem. Chem. Phys.
, 2020
, 22
, 23099